The KRT1 gene helps make keratin 1, a protein that gives the outer skin strength and helps build a stable skin barrier. If a harmful variant disrupts this job, skin can become fragile, blister easily, and later grow thick, rough, or scaly, especially on the palms and soles. This gene plays an important role in keeping skin resilient during everyday rubbing and pressure. Certain KRT1 variants are linked to inherited skin conditions such as epidermolytic ichthyosis.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
KRT1Gene function
What if the gene works
Your skin uses the KRT1 gene to make keratin 1, a protein that helps skin cells stay strong. It supports the outer skin barrier, especially in areas that handle friction such as the palms and soles.
Risk
What if the gene does not work
Variants in the KRT1 gene can weaken the skin’s support structure, often causing blistering at birth and later thick, scaly skin, sometimes with thickened palms and soles. Milder or more severe variants can affect when symptoms appear and severity.
Treatment
What does that mean for your treatment
No treatment or drug selection approach specific to the KRT1 gene is currently established in clinical guidelines. Care is usually guided by the skin findings themselves, with measures such as moisturizers, peeling creams, infection care, and sometimes retinoids used case by case rather than by KRT1 variant type.
Conditions associated with KRT1
Gene function
What if the gene works
Your outer skin needs sturdy inner fibers to handle rubbing, stretching, and daily wear. The KRT1 gene provides instructions for one of the main keratin proteins that upper skin cells use to build that support. In healthy skin, this protein works with other keratins as cells mature and move toward the surface.
The KRT1 gene helps upper skin cells build tough internal fibers called keratin filaments. These fibers act like a flexible scaffold, helping skin stay strong during everyday friction and movement.
As skin cells mature, the KRT1 gene supports the inner framework that helps them keep their shape. This helps the layers of the outer skin stay organized as new cells replace older ones.
The KRT1 gene works closely with the KRT10 gene in the upper epidermis, the outer layer of skin. Together they support normal skin cell maturation. This is a key part of what the KRT1 gene does in your skin each day.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KRT1 gene can change the keratin 1 protein so it folds poorly, clumps, or cannot form the support fibers inside skin cells. How variants in the KRT1 gene affect protein function follows a spectrum: milder variants may leave some fiber building intact, while more severe variants can disrupt the network more strongly. In established KRT1 related skin conditions, stronger disruption often links to earlier and more widespread skin thickening or blistering.
How variants are linked to conditions
Pathogenic variants in the KRT1 gene cause inherited skin conditions, most often epidermolytic ichthyosis. People with this KRT1 gene skin condition can have blistering and redness early in life, followed by thicker, rougher skin, and many also develop marked thickening on the palms and soles. Certain KRT1 variants are also linked to palmoplantar keratoderma and to a rarer form called ichthyosis hystrix of Curth-Macklin.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KRT1, risk is mainly shaped by whether you inherited a disease-causing gene change or it happened newly in you, so lifestyle does not meaningfully change the chance of having the condition. Heat, friction, and skin infections can make symptoms worse in people living with KRT1-related skin conditions.
Inheritance of KRT1 variants
KRT1-related skin conditions are usually inherited in an autosomal dominant pattern. This means a parent with a disease-causing variant in the KRT1 gene can pass it to a child with a 50% chance in each pregnancy, whether the child is a boy or a girl. In some families, KRT1 changes happen for the first time as a new, de novo variant, so the affected person did not inherit it from either parent. For people looking into how variants of the KRT1 gene are inherited, this dominant pattern is the main one recognized.
What does my KRT1 result mean for my family?
For many KRT1-related skin conditions, the pattern is dominant, which means close relatives such as a parent, child, brother, or sister may also have the same gene change and may want to learn whether it runs in the family. If a parent carries the change, each child has a 1 in 2 chance of inheriting it. Some cases happen for the first time in one person, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the KRT1 gene, doctors use KRT1 genetic testing, usually on a blood sample or saliva sample. A lab reads the gene’s DNA code and compares it with the usual sequence to look for variants that may help explain a skin condition or confirm a diagnosis.
When should I consider getting a genetic test?
Consider KRT1 testing if someone has signs of an inherited skin condition, such as blistering in infancy, thick rough skin, or marked thickening on the palms and soles, especially when it runs in the family. Testing can help confirm the cause and clarify the chance of passing it on.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they reveal depends on the condition and the kind of variant involved. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at the target tissue. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. It studies links between genes and medications to help explain why the same treatment may work differently in different people. With many drugs, genes influence both how strong an effect the medicine has and how the body processes it. This information can support treatment decisions that are better informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the KRT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so concerns about medicines, side effects, or changes in how you feel after starting a treatment are best discussed with your doctor.
History
Throughout history, people have described families in which thick, fragile, or blistering skin seemed to run from parent to child. In the late 20th century, advances in genetics gradually revealed how the KRT1 gene fit into this pattern, especially in people with epidermolytic ichthyosis, a skin condition marked by blistering and later thickened skin. Researchers linked changes in keratin genes to these inherited skin findings as DNA studies became more precise. Building on this early work, scientists identified KRT1 variants as a cause in some affected families, which helped shift diagnosis from appearance alone to gene-based confirmation. These historical steps shaped today’s understanding of inherited keratin-related skin conditions.